451 related articles for article (PubMed ID: 36678315)
1. Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan.
Sharma A; Chabloz S; Lapides RA; Roider E; Ewald CY
Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678315
[TBL] [Abstract][Full Text] [Related]
2. NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health.
Alegre GFS; Pastore GM
Curr Nutr Rep; 2023 Sep; 12(3):445-464. PubMed ID: 37273100
[TBL] [Abstract][Full Text] [Related]
3. NAD
Yoshino J; Baur JA; Imai SI
Cell Metab; 2018 Mar; 27(3):513-528. PubMed ID: 29249689
[TBL] [Abstract][Full Text] [Related]
4. Importance of NAD+ Anabolism in Metabolic, Cardiovascular and Neurodegenerative Disorders.
Helman T; Braidy N
Drugs Aging; 2023 Jan; 40(1):33-48. PubMed ID: 36510042
[TBL] [Abstract][Full Text] [Related]
5. Drugs Targeting Mechanisms of Aging to Delay Age-Related Disease and Promote Healthspan: Proceedings of a National Institute on Aging Workshop.
Espinoza SE; Khosla S; Baur JA; de Cabo R; Musi N
J Gerontol A Biol Sci Med Sci; 2023 Jun; 78(Suppl 1):53-60. PubMed ID: 37325957
[TBL] [Abstract][Full Text] [Related]
6. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
[TBL] [Abstract][Full Text] [Related]
7. The therapeutic perspective of NAD
Iqbal T; Nakagawa T
Biochem Biophys Res Commun; 2024 Apr; 702():149590. PubMed ID: 38340651
[TBL] [Abstract][Full Text] [Related]
8. Reversal of endothelial dysfunction by nicotinamide mononucleotide via extracellular conversion to nicotinamide riboside.
Mateuszuk Ł; Campagna R; Kutryb-Zając B; Kuś K; Słominska EM; Smolenski RT; Chlopicki S
Biochem Pharmacol; 2020 Aug; 178():114019. PubMed ID: 32389638
[TBL] [Abstract][Full Text] [Related]
9. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
Kahn B; Borrelli M; Libby T
J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
[TBL] [Abstract][Full Text] [Related]
10. Nutraceutical activation of Sirt1: a review.
DiNicolantonio JJ; McCarty MF; O'Keefe JH
Open Heart; 2022 Dec; 9(2):. PubMed ID: 36522127
[TBL] [Abstract][Full Text] [Related]
11. Nicotinamide mononucleotide: An emerging nutraceutical against cardiac aging?
Wei Z; Chai H; Chen Y; Cheng Y; Liu X
Curr Opin Pharmacol; 2021 Oct; 60():291-297. PubMed ID: 34507029
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial.
Yi L; Maier AB; Tao R; Lin Z; Vaidya A; Pendse S; Thasma S; Andhalkar N; Avhad G; Kumbhar V
Geroscience; 2023 Feb; 45(1):29-43. PubMed ID: 36482258
[TBL] [Abstract][Full Text] [Related]
13. Preclinical and clinical evidence of NAD
Reiten OK; Wilvang MA; Mitchell SJ; Hu Z; Fang EF
Mech Ageing Dev; 2021 Oct; 199():111567. PubMed ID: 34517020
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide mononucleotide (NMN) intake increases plasma NMN and insulin levels in healthy subjects.
Yamane T; Imai M; Bamba T; Uchiyama S
Clin Nutr ESPEN; 2023 Aug; 56():83-86. PubMed ID: 37344088
[TBL] [Abstract][Full Text] [Related]
15. NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells.
Ratajczak J; Joffraud M; Trammell SA; Ras R; Canela N; Boutant M; Kulkarni SS; Rodrigues M; Redpath P; Migaud ME; Auwerx J; Yanes O; Brenner C; Cantó C
Nat Commun; 2016 Oct; 7():13103. PubMed ID: 27725675
[TBL] [Abstract][Full Text] [Related]
16. Supplementation with NAD
Campbell JM
Nutrients; 2022 Aug; 14(15):. PubMed ID: 35956406
[TBL] [Abstract][Full Text] [Related]
17. TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity.
Ugamraj HS; Dang K; Ouisse LH; Buelow B; Chini EN; Castello G; Allison J; Clarke SC; Davison LM; Buelow R; Deng R; Iyer S; Schellenberger U; Manika SN; Bijpuria S; Musnier A; Poupon A; Cuturi MC; van Schooten W; Dalvi P
MAbs; 2022; 14(1):2095949. PubMed ID: 35867844
[TBL] [Abstract][Full Text] [Related]
18. The role of nicotinamide mononucleotide (NMN) in anti-aging, longevity, and its potential for treating chronic conditions.
Soma M; Lalam SK
Mol Biol Rep; 2022 Oct; 49(10):9737-9748. PubMed ID: 35441939
[TBL] [Abstract][Full Text] [Related]
19. Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial.
Katayoshi T; Uehata S; Nakashima N; Nakajo T; Kitajima N; Kageyama M; Tsuji-Naito K
Sci Rep; 2023 Feb; 13(1):2786. PubMed ID: 36797393
[TBL] [Abstract][Full Text] [Related]
20. Dietary Supplementation With NAD+-Boosting Compounds in Humans: Current Knowledge and Future Directions.
Freeberg KA; Udovich CC; Martens CR; Seals DR; Craighead DH
J Gerontol A Biol Sci Med Sci; 2023 Dec; 78(12):2435-2448. PubMed ID: 37068054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
